Mylan Pharmaceuticals Inc v. Merck Sharp & Dohme Corp

Michael H. Teschner

Mylan challenges Merck's sitagliptin diabetes drug patent. Prior art cited for anticipation & obviousness of its crystalline phosphate salt claims.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Roberta Pollock	400+	70%	71%
Sheridan K Snedden	500+	65%	73%
Timothy G Majors	100+	78%	58%

Name	Ratings
Mylan Pharmaceuticals Inc	L5A
DR Reddy's Laboratories Ltd	L3D
DR Reddy's Laboratories Inc	L3D
Sun Pharmaceuticals Industries Ltd	L2B

Name	Ratings
Goodwin Procter LLP	L5E
Keith A. Zullow	L3C
Winston & Strawn LLP	L5E
Jovial Wong	L3E
Lerner David Littenberg Krumholz & Mentlik LLP	L4A
Michael H. Teschner	L4D
Tedd W. van Buskirk	L3A
Russell W. Faegenburg	L2B
Katten Muchin Rosenman LLP	L3C
Jitendra Malik	L4D
Lance Soderstrom	L3C
Alissa M. Pacchioli	L3D
Heike S. Radeke	L2C
Christopher West	---- --